A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

728

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

FKB327

Solution of FKB327 for subcutaneous injection administered in a dose of 40 mg every 2 weeks for 22 weeks.

DRUG

Humira®

Solution of Humira® for subcutaneous injection administered in a dose of 40 mg every 2 weeks for 22 weeks.

Trial Locations (100)

Unknown

Research Site, Peoria

Research Site, Palm Desert

Research Site, Boca Raton

Research Site, Brandon

Research Site, Jacksonville

Research Site, Miami

Research Site, Miami Lakes

Research Site, Sarasota

Research Site, Shreveport

Research Site, Lansing

Research Site, Durham

Research Site, Middleburg Heights

Research Site, Duncansville

Research Site, Amarillo

Research Site, Austin

Research Site, Mesquite

Research Site, Plovdiv

Research Site, Sofia

Research Site, Mississauga

Research Site, Saint Catherines

Research Site, Trois-Rivières

Research Site, Osorno

Research Site, Puerto Varas

Research Site G, Santiago

Research Site M, Santiago

Research Site, Temuco

Research Site, Brno

Research Site, Hlučín

Research Site U, Prague

Research Site, Prague

Research Site, Uherské Hradiště

Research Site, Zlín

Research Site, Aachen

Research Site, Berlin

Research Site, Hamburg

Research Site, Hildesheim

Research Site, Munich

Research Site, Ratingen

Research Site B, Arequipa

Research Site M, Arequipa

Research Site CA, Lima

Research Site CH, Lima

Research Site PA, Lima

Research Site PE, Lima

Research Site S, Lima

Research Site D, Bialystok

Research Site R, Bialystok

Research Site, Gdynia

Research Site, Katowice

Research Site KL, Krakow

Research Site KR, Krakow

Research Site, Lublin

Research Site P, Poznan

Research Site RH, Poznan

Research Site, Torun

Research Site, Oradea

Research Site, Brasov

Research Site, Brăila

Research Site C, Bucharest

Research Site R, Bucharest

Research Site T, Bucharest

Research Site, Constanța

Research Site, Galati

Research Site, Sfântu Gheorghe

Research Site, Ufa

Research Site, Petrozavodsk

Research Site, Kazan'

Research Site D, Moscow

Research Site SM, Moscow

Research Site ST, Moscow

Research Site, Nizhny Novgorod

Research Site, Penza

Research Site, Perm

Research Site, Ryazan

Research Site B, Saint Petersburg

Research Site Z, Saint Petersburg

Research Site, Saratov

Research Site, Smolensk

Research Site, Vladimir

Research Site E, Yaroslavl

Research Site S, Yaroslavl

Research Site, Santiago de Compostela

Research Site, Bilbao

Research Site A, Barcelona

Research Site G, Barcelona

Research Site, Málaga

Research Site, Chernivtsi

Research Site, Ivano-Frankivsk

Research Site A, Kyiv

Research Site B, Kyiv

Research Site P, Kyiv

Research Site, Lutsk

Research Site C, Lviv

Research Site N, Lviv

Research Site, Poltava

Research Site, Ternopil

Research Site, Uzhhorod

Research Site G, Vinnytsia

Research Site Sh, Vinnytsia

Research Site St, Vinnytsia

All Listed Sponsors
lead

Fujifilm Kyowa Kirin Biologics Co., Ltd.

INDUSTRY

NCT02260791 - A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients | Biotech Hunter | Biotech Hunter